Insulin action in man

Diabetes and Metabolism

Volumn 22, Issue 2, 1996, Pages 105-110

  Scheen, A J ^a   Lefebvre P J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Glucose clamp; Insulin resistance; Insulin sensitivity; Intravenous glucose tolerance test; Minimal model; Syndrome X; Type 2 diabetes

Indexed keywords

INSULIN;

CONFERENCE PAPER; DRUG EFFECT; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; SYNDROME X;

COMPUTER SIMULATION; DIABETES MELLITUS, TYPE 2; GLUCONEOGENESIS; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; MICROVASCULAR ANGINA; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; RECEPTOR, INSULIN;

EID: 0029930505     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Begman RN, Finegood DT, Ader M. Assessment of insulin sensitivy in vivo. Endocr Rev, 1985, 6, 45-86.
2. Gerich JE. Control of glycaemia. Baillière's, Clin Endocrinol Metab, 1993, 7, 551-586.
3. Reaven GM. Role of insulin resistance in human disease. Diabetes, 1988, 37, 1595-1607.
4. DeFronzo RA, Ferrannint E. Insulin resistance : a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care, 1991, 14, 173-194.
5. Moller DE. Insulin resistance John Wiley and Sons, Chichester, 425 p, 1993
6. Ferrannini E (ed). Insulin resistance and disease. Baillière's Clin Endocrinol Metab., 1993, 7, 785-1105.
7. Ferrannini E, DeFronzo RA. Insulin actions in viva : glucose metabolism. In : Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, eds. International Textbook of Diabetes Mellitus, John Wiley & Sons Ltd. Chichester, 1992, 409-438
8. Yki-Järvinen H. Action of insulin on glucose metabolism in vivo. Baillière's Clin Endocrinol Metab, 1993, 7, 903-927.
9. Schecn AJ, Lefèbvre PJ. Assessment of insulin sensitivity in vivo. Application to the study of Type-2 diabetes. Horm Res. 1992, 38, 19-27.
10. Scheen AJ, Paquot N, Castillo MJ. Lefèbvre PJ. How to measure insulin action in vivo. Diabetes Metab Rev, 1994, 10, 151-188.
11. Scheen AJ, Paquot N, Letiexhe MR, Castillo MJ, Lefèbvre PJ. Comment mesurer la sensibilité à l'insuline en pratique ? Diabete Metab, 1994, 20, 556-561.
12. Saad MF, Anderson RL, Laws A et al. for the Insulin Resistance Atherosclerosis Study. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes, 1994, 43, 1114-1121.
13. Scheen AJ, Paquot N, Letiexhe MR, Castillo MJ. Lefèbvre PJ. Comment explorer la sensibilité à l'insuline chez l'homme ? Ann Endocrinol (Paris), 1995, 56, 523-529.
14. Himsworth HP Diabetes mellitus. Its differentiation into insulin-sensitive and insulin-insensitive types. Lancet, 1936. 1, 127-130.
15. Grulet H, Leutenegger M. Tests de tolérance à l'insuline. Presse Med, 1994, 23, 943-947
16. Reaven GM Insulin-resistance in noninsulin-dependent diabetes mellitus . does it exist and can it be measured ? Am J Med, 1983, 74 (Suppl). 3-17
17. Davis SN, Monti L, Piatti PM et al. Estimates of insulin action in normal, obese and NIDDM man comparison of insulin and glucose infusion test, CIGMA, minimal model and glucose clamp techniques. Diabetes Res, 1993, 23, 1-18.
18. Piatti PM, Monti LD, Caumo A et al. The continuous low dose insulin and glucose infusion test. a simplified and accurate method for the evaluation of insulin sensitivity and insulin secretion in population studies J Clin Endocrinol Metab, 1995, 80, 34-40
19. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique : a method for quantifying insulin secretion and resistance. Am J Physiol, 1979, 232, E214-223.
20. Scheen AJ, Paquot N, Letiexhe M, Paolisso G, Castillo MJ, Lefèbvre PJ. Glucose metabolism in obesity : lessons from OGTT, IVGTT, and clamp studies. Int J Obesity, 1995, 19, Suppl 3, S14-S20.
21. Ng LL Application of modelling techniques to the assessment of insulin sensitivity in man Diabetic Med, 1988, 5, 217-222
22. Turner RC. Rudenski AS, Matthews DR, Levy JC, O'Rahilly SP, Hosker JP. Application of a structural model of glucose-insulin relations to assess beta-cell function and insulin sensitivity Horm Metabol Res, 1990, 24 (Suppl.), 66-71.
23. Bergman RN, Towards physiological understanding of glucose tolerance. Minimal-model approach. Diabetes, 1989, 38, 1512-1527
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment : insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985, 28, 412-419.
25. Hosker JP, Matthews DR, Rudenski AS et al Continuous infusion of glucose with model assessment : measurement of insulin resistance and ß-cell function in man. Diabetologia, 1985, 28, 401-411.
26. Duysinx BC, Scheen AJ, Gérard PL, Letiexhe M, Paquot N, Lefebvre PJ. Measurement of insulin sensitivity by the minimal model method using a simplified intravenous glucose tolerance test : validity and reproducibility. Diabete Metab, 1994, 20, 425-432.
27. Garvey WT. Birnbaum M. Cellular insulin action and insulin resistance. Baillière's Clin Endocrinol Metab. 1993, 7, 785-873.
28. Kahn CR. Insulin action, diabetogenes, and the cause of Type 2 diabetes. Diabetes, 1994, 43, 1066-1084
29. Lillioja S, Young AA, Cutler CL et al. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest, 1987, 80, 415-424.
30. Bergman RN, Steil GM, Bradley DC, Wanatabe RM. Modeling of insulin action in vivo. Annu Rev Physiol, 1992, 54, 861-883.
31. Ganrot PO. Insulin resistance syndrome : possible key role of blood flow in resting muscle. Diabetologia, 1993, 36, 876-879.
32. Baron AD. Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone. Baillière's Clin Endocrinol Metab, 1993, 7, 961-987.
33. Goldstein BJ, Kahn CR. Insulin receptors in normal and disease states. In : Alberti KGMM, DeFronzo RA. Keen H, Zimmet P, eds. International textbook of diabetes mellitus. John Wiley & Sons Ltd. Chichester, 1992, 357-383.
34. Háring HU, Mehnert H Pathogenesis of Type-2 (non-insulin-dependent) diabetes mellitus candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle. Diabetologia. 1993, 36, 176-182.
35. Beck-Nielsen H, Groop LC. Metabolic and genetic characterization of prediabetic states Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest, 1994, 94, 1714-1721
36. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992, 15, 318-368.
37. Felber JP, Haesler E, Jéquier E. Metabolic origin of insulin resistance in obesity with and without Type-2 (non-insulin-dependent) diabetes mellitus Diabetologia, 1993, 36, 1221-1229.
38. Groop LG, Ferrannini E. Insulin action and substrate competition. Baillière's Clin Endocrinol Metab. 1993, 7, 1007-1032.
39. Ferrannini E, Groop LC. Hepatic glucose production in insulin-resistant states. Diabetes Metab Rev, 1989, 5, 711-725.
40. Scheen AJ, Lefèbvre PJ. Pathophysiology of Type-2 diabetes. In : Kuhlmann J, Puls W, Eds., Handbook of Experimental Pharmacology, Oral Antidiabetics, Springer Verlag, Berlin, 1995, 7-42.
41. Dinneen S, Gerich J, Rizza R. Carbohydrate metabolism in noninsulin-dependent diabetes mellitus N Engl J Med, 1992, 327, 707-713.
42. Mitrakou A, Kelley D, Mokan M et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med, 1992, 326, 22-29.
43. Beck-Nielsen H, Vaag A, Damsbo P et al. Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care, 1992, 15, 418-429.
44. DelPrato S, Bonadonna RC, Bonora E et al Characterization of cellular defects of insulin action in Type-2 (non-insulin-dependent) diabetes mellitus. J Clin Invest, 1993, 91, 484-494.
45. Taylor SI, Accili D, Imai Y. Insulin resistance or insulin deficiency Which is the primary cause of NIDDM ? Diabetes, 1994, 43, 735-740.
46. O'Rahilly S, Hattersley A, Vaag A. Gray H. Insulin resistance as the major cause of impaired glucose tolerance : a self-fulfilling prophesy ? Lancet, 1994, 344, 585-589.
47. Lefèbvre PJ Syndrome X. Diab Nutr Metab, 1993, 6, 61-65.
48. Lebovitz HE. Syndrome X . fact or fiction ? In : Lefèbvre PJ, Standl E, Eds., New aspects in diabetes Treatment strategies with alpha-glucosidase inhibitors, W. de Gruyter, Berlin, New York, 1992, 23-33.
49. Fontbonne A, André Ph, Eschwège E and the BIGPRO Study Group. BIGPRO (Biguanides and Prevention of the Risk of Obesity) : Study design. A randomized trial of metformin versus placebo in the correction of the metabolic abnormalities associated with insulin resistance. Diabete Metab, 1991, 17, 249-254
50. Scheen AJ, Lefèbvre PJ. Pharmacological treatment of the obese diabetic patient. Diabete Metab, 1993, 19, 547-559
51. Lefèbvre PJ, Scheen AJ. Improving the action of insulin. Clin Invest Med, 1995, 18, 340-347